Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats

INTRODUCTION: Doxorubicin (DOX) is a well-known anticancer drug. However its clinical use has been limited due to cardiotoxic effects. One of the major concerns with DOX therapy is its toxicity in patients who are frail, particularly diabetics. Several studies suggest that mesenchymal stem cells (MS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ammar, Hania Ibrahim, Sequiera, Glen Lester, Nashed, Mira B., Ammar, Rasha I., Gabr, Hala M., Elsayed, Hany E., Sareen, Niketa, Rub, Ejlal Abu-El, Zickri, Maha B., Dhingra, Sanjiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546321/
https://www.ncbi.nlm.nih.gov/pubmed/26296856
http://dx.doi.org/10.1186/s13287-015-0142-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546321/
https://www.ncbi.nlm.nih.gov/pubmed/26296856
http://dx.doi.org/10.1186/s13287-015-0142-x

Ejemplares similares